JP2022502362A5 - - Google Patents

Info

Publication number
JP2022502362A5
JP2022502362A5 JP2021514980A JP2021514980A JP2022502362A5 JP 2022502362 A5 JP2022502362 A5 JP 2022502362A5 JP 2021514980 A JP2021514980 A JP 2021514980A JP 2021514980 A JP2021514980 A JP 2021514980A JP 2022502362 A5 JP2022502362 A5 JP 2022502362A5
Authority
JP
Japan
Prior art keywords
phenyl
ethynyl
hydroxy
propyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021514980A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502362A (ja
JP7495395B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/052021 external-priority patent/WO2020061375A1/en
Publication of JP2022502362A publication Critical patent/JP2022502362A/ja
Publication of JP2022502362A5 publication Critical patent/JP2022502362A5/ja
Application granted granted Critical
Publication of JP7495395B2 publication Critical patent/JP7495395B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514980A 2018-09-20 2019-09-19 抗菌性化合物 Active JP7495395B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862734173P 2018-09-20 2018-09-20
US62/734,173 2018-09-20
US201862767313P 2018-11-14 2018-11-14
US62/767,313 2018-11-14
PCT/US2019/052021 WO2020061375A1 (en) 2018-09-20 2019-09-19 Antibacterial compounds

Publications (3)

Publication Number Publication Date
JP2022502362A JP2022502362A (ja) 2022-01-11
JP2022502362A5 true JP2022502362A5 (cg-RX-API-DMAC7.html) 2022-09-27
JP7495395B2 JP7495395B2 (ja) 2024-06-04

Family

ID=69887856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514980A Active JP7495395B2 (ja) 2018-09-20 2019-09-19 抗菌性化合物

Country Status (13)

Country Link
US (3) US11407740B2 (cg-RX-API-DMAC7.html)
EP (1) EP3853210A4 (cg-RX-API-DMAC7.html)
JP (1) JP7495395B2 (cg-RX-API-DMAC7.html)
KR (1) KR102954539B1 (cg-RX-API-DMAC7.html)
CN (1) CN113166077B (cg-RX-API-DMAC7.html)
AU (1) AU2019345150A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021005044A2 (cg-RX-API-DMAC7.html)
CA (1) CA3113226A1 (cg-RX-API-DMAC7.html)
IL (1) IL281614B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021003084A (cg-RX-API-DMAC7.html)
SG (1) SG11202102712WA (cg-RX-API-DMAC7.html)
TW (1) TWI900469B (cg-RX-API-DMAC7.html)
WO (1) WO2020061375A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3374350B1 (en) 2015-11-09 2022-01-05 Forge Therapeutics, Inc. Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
EP3621962A4 (en) 2017-05-10 2020-12-09 Forge Therapeutics, Inc. ANTIBACTERIAL COMPOUNDS
WO2020061375A1 (en) 2018-09-20 2020-03-26 Forge Therapeutics, Inc. Antibacterial compounds
EP4700030A3 (en) 2019-11-14 2026-03-18 Amgen, Inc. Improved synthesis of kras g12c inhibitor compound
WO2021195260A1 (en) * 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor and methods of making
WO2021195258A1 (en) * 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor, formulations, and uses thereof
WO2023011573A1 (zh) * 2021-08-05 2023-02-09 浙江海正药业股份有限公司 芳香乙炔类衍生物及其制备方法和用途
WO2023011574A1 (zh) * 2021-08-05 2023-02-09 浙江海正药业股份有限公司 芳香乙炔类衍生物及其制备方法和用途
AR127139A1 (es) * 2021-09-28 2023-12-20 Forge Therapeutics Inc Inhibidores de lpxc y usos de estos
EP4568955A4 (en) * 2022-08-10 2026-08-12 Blacksmith Medicines Inc ANTIBACTERIAL COMPOUNDS

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK273689A (da) * 1988-06-06 1989-12-07 Sanofi Sa 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
KR100477070B1 (ko) 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
US5543534A (en) 1994-12-29 1996-08-06 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6699849B1 (en) 1998-02-23 2004-03-02 Cyclops, Ehf. Cyclodextrin complexes of benzodiazepines
US6875619B2 (en) 1999-11-12 2005-04-05 Motorola, Inc. Microfluidic devices comprising biochannels
US20050009101A1 (en) 2001-05-17 2005-01-13 Motorola, Inc. Microfluidic devices comprising biochannels
ATE530520T1 (de) 2001-08-10 2011-11-15 Shionogi & Co Antivirales mittel
AR037641A1 (es) 2001-12-05 2004-11-17 Tularik Inc Moduladores de inflamacion
CN1688291A (zh) 2002-02-01 2005-10-26 辉瑞产品公司 含有固体药物分散体的即刻释放剂型
ES2387803T3 (es) 2003-01-08 2012-10-02 Novartis Vaccines And Diagnostics, Inc. Agentes antibacterianos
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
TW200526635A (en) 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
WO2005110399A2 (en) 2004-04-29 2005-11-24 The Regents Of The University Of California Zinc-binding groups for metalloprotein inhibitors
WO2006028523A2 (en) 2004-04-29 2006-03-16 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CN101528711A (zh) 2006-08-31 2009-09-09 先灵公司 可用作抗细菌剂的乙内酰脲衍生物
EA200970349A1 (ru) 2006-10-05 2010-02-26 Янссен Фармацевтика Н.В. Ингибиторы металлопротеазы гетероциклического происхождения
CA2691987C (en) 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents
US8871728B2 (en) * 2007-06-29 2014-10-28 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
WO2010059838A2 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Pde4 inhibitors selective for the long form of pde4 for treating inflammation and avoiding side effects
IT1392249B1 (it) 2008-11-28 2012-02-22 Univ Degli Studi Urbino Derivati di [(3-idrossi-4-piron-2-il)metil]-amina e loro uso come farmaci anti-neoplastici
WO2010100475A1 (en) 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
WO2012151567A1 (en) * 2011-05-05 2012-11-08 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for preventing and treating influenza
WO2012177635A1 (en) 2011-06-19 2012-12-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
EP2847174B1 (en) 2012-04-03 2017-05-17 Bristol-Myers Squibb Company Pyrimidinone carboxamides as inhibitors of endothelial lipase
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
HK1211289A1 (en) * 2012-08-06 2016-05-20 Savira Pharmaceuticals Gmbh Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
AU2014209107B2 (en) 2013-01-28 2018-04-12 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
WO2014160649A1 (en) * 2013-03-29 2014-10-02 Novartis Ag Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
AU2014306451B2 (en) * 2013-08-16 2019-01-17 Duke University Substituted hydroxamic acid compounds
WO2015085238A1 (en) 2013-12-05 2015-06-11 The Regents Of The University Of California, A California Corporation Inhibitors of lpxc
US9988373B2 (en) 2013-12-26 2018-06-05 Shionogi & Co., Ltd. Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same
CA2960949A1 (en) 2014-09-12 2016-03-17 Tatsuya Honda Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
HUE047225T2 (hu) 2014-12-16 2020-04-28 Novartis Ag LpxC inhibitor izoxazol hidroxámsav-vegyületek
CN105777464B (zh) 2014-12-26 2020-09-29 中国科学院上海药物研究所 异羟肟酸衍生物及其制备方法和应用
US10611747B2 (en) 2015-11-09 2020-04-07 Forge Therapeutics, Inc. Pyrone based compounds for treating bacterial infections
EP3374350B1 (en) 2015-11-09 2022-01-05 Forge Therapeutics, Inc. Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
EP3190103A1 (en) * 2016-01-08 2017-07-12 Rijksuniversiteit Groningen Inhibitors of the pd-1/pd-l1 protein/protein interaction
US10889556B2 (en) 2016-03-08 2021-01-12 The Regents Of The University Of California Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease
US11034650B2 (en) * 2016-12-23 2021-06-15 Intervet Inc. Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
US20200062789A1 (en) 2017-01-31 2020-02-27 Fujifilm Toyama Chemical Co., Ltd. Hydroxamic acid prodrug compound or salt thereof, lyophilized formulation, lpxc inhibitor, and antibacterial agent
EP3621962A4 (en) 2017-05-10 2020-12-09 Forge Therapeutics, Inc. ANTIBACTERIAL COMPOUNDS
WO2018208987A2 (en) 2017-05-10 2018-11-15 Forge Therapeutics, Inc. Antibacterial compounds
WO2018216822A1 (en) 2017-05-25 2018-11-29 Taisho Pharmaceutical Co., Ltd. Novel imidazole derivatives
WO2019086452A1 (en) * 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds
KR102868718B1 (ko) 2018-02-10 2025-10-14 케이비피 바이오사이언시즈 씨오., 엘티디. 항생제로서 작용하는 화합물
WO2020061375A1 (en) 2018-09-20 2020-03-26 Forge Therapeutics, Inc. Antibacterial compounds
US20220081421A1 (en) 2018-11-14 2022-03-17 Forge Therapeutics, Inc. Antibacterial compounds
WO2021195260A1 (en) 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor and methods of making
WO2021195258A1 (en) 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor, formulations, and uses thereof
WO2022086920A1 (en) 2020-10-20 2022-04-28 Blacksmith Medicines, Inc. Glutaminyl-peptide cyclotransferase like (qpctl) protein inhibitors and uses thereof
AR124839A1 (es) 2021-02-11 2023-05-10 Forge Therapeutics Inc Compuestos antibacterianos
EP4291550A4 (en) * 2021-02-11 2025-01-22 Blacksmith Medicines, Inc. Antibacterial compounds
AR127139A1 (es) * 2021-09-28 2023-12-20 Forge Therapeutics Inc Inhibidores de lpxc y usos de estos
EP4568955A4 (en) 2022-08-10 2026-08-12 Blacksmith Medicines Inc ANTIBACTERIAL COMPOUNDS
WO2024036170A1 (en) 2022-08-10 2024-02-15 Blacksmith Medicines, Inc. Antibacterial compounds

Similar Documents

Publication Publication Date Title
JP2021515033A5 (cg-RX-API-DMAC7.html)
JP2025186368A5 (cg-RX-API-DMAC7.html)
RU2013150349A (ru) 5-замещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов васе, содержащие их композиции и их применение
JP2021524484A5 (cg-RX-API-DMAC7.html)
RU2017135520A (ru) Бициклические производные хиназолинона
JP2022517189A5 (cg-RX-API-DMAC7.html)
JP2023517680A5 (cg-RX-API-DMAC7.html)
JP2022542396A5 (cg-RX-API-DMAC7.html)
JP2022552655A5 (cg-RX-API-DMAC7.html)
JP2022554169A5 (cg-RX-API-DMAC7.html)
RU2009125916A (ru) Соединения-ингибиторы фосфоинозитид 3-киназы и способы применения
IL264982B (en) Hetero(aryl)cyclopropylamine compounds as lsd1 inhibitors
RU2014124950A (ru) Производные 2-фениламинопиримидина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2) для лечения болезни паркинсона
JP2015533782A (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
JP2022501429A5 (cg-RX-API-DMAC7.html)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
JP2013531070A5 (cg-RX-API-DMAC7.html)
RU2019136279A (ru) C5 -Анилинохиназолиновые соединения и их использование в лечении рака
RU2006101541A (ru) Производные пиперазина и способ их применения
JP2021515004A5 (cg-RX-API-DMAC7.html)
JP2022511209A5 (cg-RX-API-DMAC7.html)
JP2018512408A5 (cg-RX-API-DMAC7.html)
CA2803055A1 (en) Heteroaryl compounds and compositions as protein kinase inhibitors
RU2015144385A (ru) Ациклические цианоэтилпиразолопиридоны в качестве ингибиторов янус-киназы
JP2024517861A5 (cg-RX-API-DMAC7.html)